131 related articles for article (PubMed ID: 31325663)
21. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
22. Malignant pleural effusion treatment outcomes: pleurodesis via video-assisted thoracic surgery (VATS) versus tube thoracostomy.
Luh SP; Chen CY; Tzao CY
Thorac Cardiovasc Surg; 2006 Aug; 54(5):332-6. PubMed ID: 16902882
[TBL] [Abstract][Full Text] [Related]
23. What is the best treatment for malignant pleural effusions?
Zahid I; Routledge T; Billè A; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):818-23. PubMed ID: 21325469
[TBL] [Abstract][Full Text] [Related]
24. Pleural fluid osteopontin, vascular endothelial growth factor, and urokinase-type plasminogen activator levels as predictors of pleurodesis outcome and prognosticators in patients with malignant pleural effusion: a prospective cohort study.
Hsu LH; Hsu PC; Liao TL; Feng AC; Chu NM; Kao SH
BMC Cancer; 2016 Jul; 16():463. PubMed ID: 27411914
[TBL] [Abstract][Full Text] [Related]
25. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
[TBL] [Abstract][Full Text] [Related]
26. Protocol of the Australasian Malignant Pleural Effusion-2 (AMPLE-2) trial: a multicentre randomised study of aggressive versus symptom-guided drainage via indwelling pleural catheters.
Azzopardi M; Thomas R; Muruganandan S; Lam DC; Garske LA; Kwan BC; Rashid Ali MR; Nguyen PT; Yap E; Horwood FC; Ritchie AJ; Bint M; Tobin CL; Shrestha R; Piccolo F; De Chaneet CC; Creaney J; Newton RU; Hendrie D; Murray K; Read CA; Feller-Kopman D; Maskell NA; Lee YC
BMJ Open; 2016 Jul; 6(7):e011480. PubMed ID: 27381209
[TBL] [Abstract][Full Text] [Related]
27. [Tetracycline pleurodesis for treatment of malignant pleural effusions. Retrospective study of 91 cases].
Martínez Moragón E; Aparicio Urtasun J; Sanchis Aldás J; Fullana Monllor J; Sanchis Moret F; Montalar Salcedo J; Marco Martínez V
Med Clin (Barc); 1993 Jul; 101(6):201-4. PubMed ID: 8332018
[TBL] [Abstract][Full Text] [Related]
28. [Early Video-Assisted Thoracic Surgery (VATS) improves quality of life In complicated Neoplastic Pleural Effusions.].
Alvarez Padilla FN; Schiavoni EN; Bustos MEF
Rev Fac Cien Med Univ Nac Cordoba; 2017 Dec; 74(4):379-385. PubMed ID: 29902147
[TBL] [Abstract][Full Text] [Related]
29. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
30. Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis.
Srour N; Amjadi K; Forster A; Aaron S
Can Respir J; 2013; 20(2):106-10. PubMed ID: 23616967
[TBL] [Abstract][Full Text] [Related]
31. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
32. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease.
Burrows CM; Mathews WC; Colt HG
Chest; 2000 Jan; 117(1):73-8. PubMed ID: 10631202
[TBL] [Abstract][Full Text] [Related]
33. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the diagnosis and management of malignant pleural effusions.
Heffner JE; Klein JS
Mayo Clin Proc; 2008 Feb; 83(2):235-50. PubMed ID: 18241636
[TBL] [Abstract][Full Text] [Related]
35. Tunneled pleural catheter use for pleural palliation does not increase infection rate in patients with treatment-related immunosuppression.
Wilshire CL; Gilbert CR; Louie BE; Aye RW; Farivar AS; Vallières E; Gorden JA
Support Care Cancer; 2018 May; 26(5):1525-1531. PubMed ID: 29188375
[TBL] [Abstract][Full Text] [Related]
36. The Low-Cost, Long-Term Indwelling Pleural Catheter (LunGO): An Inexpensive and Effective Alternative for the Management of Dyspnea Associated with Malignant Pleural Effusions.
de Abreu IRLB; Bina Biazzotto AF; Santos MA; de Souza AAC; Abrão FC; Cavalcante MGC
Respiration; 2019; 98(2):151-156. PubMed ID: 31018214
[TBL] [Abstract][Full Text] [Related]
37. Home-management of malignant pleural effusion with an indwelling pleural catheter: ten years experience.
Bertolaccini L; Viti A; Gorla A; Terzi A
Eur J Surg Oncol; 2012 Dec; 38(12):1161-4. PubMed ID: 22959168
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.
Cardillo G; Facciolo F; Carbone L; Regal M; Corzani F; Ricci A; Di Martino M; Martelli M
Eur J Cardiothorac Surg; 2002 Feb; 21(2):302-5; discussion 305-6. PubMed ID: 11825740
[TBL] [Abstract][Full Text] [Related]
39. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.
Musani AI; Haas AR; Seijo L; Wilby M; Sterman DH
Respiration; 2004; 71(6):559-66. PubMed ID: 15627865
[TBL] [Abstract][Full Text] [Related]
40. Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery.
Benkó I; Molnár TF; Horváth OP
Acta Chir Hung; 1999; 38(2):131-3. PubMed ID: 10596313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
